STAAR Surgical Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8523123052
USD
19.19
0.68 (3.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
AtriCure, Inc.
iRhythm Technologies, Inc.
ICU Medical, Inc.
CONMED Corp.
Integer Holdings Corp.
LivaNova Plc
InMode Ltd.
Axonics, Inc.
STAAR Surgical Co.
Pacific Biosciences of California, Inc.
Integra LifeSciences Holdings Corp.

Why is STAAR Surgical Co. ?

1
Poor Management Efficiency with a low ROE of 5.89%
  • The company has been able to generate a Return on Equity (avg) of 5.89% signifying low profitability per unit of shareholders funds
2
Flat results in Sep 25
  • NET SALES(HY) At USD 139.05 MM has Grown at -25.88%
  • NET PROFIT(HY) At USD 9.61 MM has Grown at -44.62%
  • OPERATING CASH FLOW(Y) Lowest at USD -29.67 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 6.75%, its profits have fallen by -461.9%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is STAAR Surgical Co. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
STAAR Surgical Co.
7.99%
-0.74
67.36%
S&P 500
13.68%
0.71
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
8.08%
EBIT Growth (5y)
-261.15%
EBIT to Interest (avg)
8.83
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.63
Sales to Capital Employed (avg)
0.78
Tax Ratio
15.90%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
22.61%
ROE (avg)
5.89%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.53
EV to EBIT
-10.80
EV to EBITDA
-12.45
EV to Capital Employed
4.25
EV to Sales
3.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-39.38%
ROE (Latest)
-22.28%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -4.69% (YoY

NET SALES(Q)

Highest at USD 94.73 MM

OPERATING PROFIT(Q)

Highest at USD 46.49 MM

OPERATING PROFIT MARGIN(Q)

Highest at 49.08 %

PRE-TAX PROFIT(Q)

Highest at USD 44.79 MM

NET PROFIT(Q)

Highest at USD 21.18 MM

-21What is not working for the Company
NET SALES(HY)

At USD 139.05 MM has Grown at -25.88%

NET PROFIT(HY)

At USD 9.61 MM has Grown at -44.62%

OPERATING CASH FLOW(Y)

Lowest at USD -29.67 MM

ROCE(HY)

Lowest at -24.65%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.37 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.69 times

Here's what is working for STAAR Surgical Co.

Pre-Tax Profit
At USD 44.79 MM has Grown at 240.38%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 21.18 MM has Grown at 112.19%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Sales
Highest at USD 94.73 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 46.49 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 49.08 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 44.79 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 21.18 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Raw Material Cost
Fallen by -4.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for STAAR Surgical Co.

Inventory Turnover Ratio
Lowest at 1.37 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Operating Cash Flow
Lowest at USD -29.67 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Debtors Turnover Ratio
Lowest at 2.69 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio